Results 111 to 120 of about 48,143 (212)

Isolation and characterization of PDE-I and II, the inhibitors of cyclic adenosine-3',5'-monophosphate phosphodiesterase.

, 1978
Yûji Enomoto, Yoshio Furutani, HIROSHI NAGANAWA, MASA HAMADA, TOMIO TAKEUCHI, HAMAO UMEZAWA   +5 more
openalex   +2 more sources

A heat‐stable inhibitor protein for bovine brain cyclic nucleotide phosphodiesterase from Escherichia coli [PDF]

, 1981
Yasushi Iwasa, Kosei Yonemitsu, Kazuo Matsui, Kohji Fukunaga, Eishichi Miyamoto   +4 more
openalex   +1 more source

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

Frontiers in Pharmacology
Phosphodiesterase 4 (PDE4) inhibitors are effective therapeutic agents for various inflammatory diseases. Roflumilast, apremilast, and crisaborole have been developed and approved for the treatment of chronic obstructive pulmonary disease psoriatic ...
Tianfei Fan, Wenjing Wang, Yao Wang, Mingtang Zeng, Yi Liu, Shuyao Zhu, Lin Yang   +6 more
doaj   +1 more source

Inhibitors of cyclic nucleotide phosphodiesterases produced by streptomyces. IV. Inhibition of cyclic nucleotide phosphodiesterases by reticulol.

, 1977
Yoshio Furutani, TOMIO TAKEUCHI, HAMAO UMEZAWA   +2 more
openalex   +2 more sources

Stimulatory effects of adenosine, adenosine analogs and insulin on adipose tissue lipoprotein lipase activity and their prevention by phosphodiesterase inhibitors [PDF]

, 1984
Anne-Marie Bourdeaux, Roger Nordmann, Yves Giudicelli   +2 more
openalex   +1 more source

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives

Patient Preference and Adherence, 2009
Pierre Costa1, Thierry Grivel2, Naji Gehchan31Service d’Urologie–Andrologie, Hôpital Caremeau, Nîmes, France; 2159, Avenue Sainte-Marguerite, Nice, France; 3Eli Lilly and Company, Lilly France – Medical ...
Pierre Costa, Thierry Grivel, Naji Gehchan   +2 more
doaj  

The Contracting and Swallowing Activity of Arterial Endothelial Cells Visualized by Carbon Technique (Shimamoto 1973) and the Inhibitory Effect of Cyclic AMP Phosphodiesterase Inhibitors, EG467 and EG626

, 1974
Takio Shimamoto
openalex   +2 more sources

Avanafil for treatment of erectile dysfunction: review of its potential

Vascular Health and Risk Management, 2012
Ryan M Burke,1 Jeffery D Evans21The University of Louisiana at Monroe College of Pharmacy, Monroe, LA, 2The University of Louisiana at Monroe College of Pharmacy, Shreveport, LA, USAAbstract: Avanafil is a medication that was recently approved by the US ...
Burke RM, Evans JD
doaj  

Iijima Y., F. Nakagawa, S. Handa, T. Oda, A. Naito and M. Yamazaki, Biological properties of griseolic acid, a cyclic AMP phosphodiesterase inhibitor with an adenine group (1985) FEBS Letters 192, 179‐183 [PDF]

, 1986

openalex   +1 more source

The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function [PDF]

, 1990
Kenneth Murray, P. England, Trevor J. Hallam, J.P. Maguire, Kitty Moores, Martin L. Reeves, Alec W.M. Simpson, T J Rink   +7 more
openalex   +1 more source